Interview: Anders Fogstrup, Country Manager, Norpharma, Denmark
Country Manager of Norpharma, Denmark, discusses how the company has been able to remain a market competitor while…
Norpharma, Denmark
Last updated: 13.02.2014
Norpharma A/S (Norpharma) is a pharmaceutical company engaged in the manufacture and marketing of pharmaceutical products. The company is a integral part of Napp Group. Norpharma principally focuses on developing medicines for the treatment of pain and cancer related problems. The product portfolio of the company include Prioderm, Hedrin, DoloTest and Order Todolac.
It has collaborated with cohn&wolfe company to develop new treatment principle for the control of persistent pain. It markets its products in domestic market through its own sales force and in international market through distributors. Norpharma is a headquartered in Horsholm, Denmark.
Norpharma A/S
Slotsmarken 15
2970 Hørsholm
Danmark
45 45 17 48 00
http://www.norpharma.dk/
Interviews
Related
Jan van de Winkel – President & CEO, Genmab
The future of drug development is about interacting, sharing and collaborating. The President and CEO of Genmab, an…
Interview: Anders Fogstrup, Country Manager, Norpharma, Denmark
Country Manager of Norpharma, Denmark, discusses how the company has been able to remain a market competitor while…
Interview: Lars Johansson, Managing Director Nordics, Janssen
Janssen has historically had a very strong focus on emerging markets. In today’s world, where growth for the…
Biotech as business: the Bavarian Nordic story
If there is one thing that successful Danish companies have in common with one another, it is the clear…
Interview: Christian Dyvig, CEO, Lundbeck Foundation
The CEO of one of Denmark’s largest foundations talks about the merits of the foundation model, and the…
Interview: Morten Nielsen, CEO, NNE Pharmaplan, Denmark
The CEO of NNE Pharmaplan, the world’s leading engineering and consultancy focused in the fields of pharma…
Interview: Tom Rönnlund, General Manager Nordic & Baltic Region, IMS…
Tom Rönnlund discusses the current state of the pharmaceutical industry in the Nordics in this time of…
Interview: Jens Holmstrup, Managing Director, Pfizer Denmark
Holmstrup discusses the patent cliff and its effect on Pfizer’s business in Denmark, before going on to discuss…
Interview: Pia Olsen Dyhr, Minister of Trade & Investment, Denmark
Pia Olsen Dyhr is a member of the Danish Folketing (Parliament) for the Socialist People’s Party in the North…
The Nordics: Making a Virtue of Necessity
“The Nordic region—the ‘quiet North’ as it could have been called—counterbalances the turbulence in…
Interview: Else Smith, Director General, CEO, The Danish Health and Medicines…
After the big milestone last year— the Danish Medicines Agency merging with the Danish National Board of…
Interview: Ulf Wiinberg, CEO, Lundbeck
Ulf Wiinberg has been CEO of Lundbeck since June 2008. He was previously with Wyeth for 27 years. Ulf Wiinberg is a…
